These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6308493)

  • 1. Enhanced stereotyped response to amphetamine after pretreatment with small doses of molindone.
    Conway P; Uretsky NJ
    Neuropharmacology; 1983 May; 22(5):579-86. PubMed ID: 6308493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats.
    Meller E
    Psychopharmacology (Berl); 1982; 76(3):222-7. PubMed ID: 6808540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
    Conway PG; Uretsky NJ
    J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychopharmacological investigation of the monoamine oxidase inhibitory activity of molindone, a dihydroindolone neuroleptic.
    Balsara JJ; Gada VP; Nandal NV; Chandorkar AG
    J Pharm Pharmacol; 1984 Sep; 36(9):608-13. PubMed ID: 6149285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of molindone on central dopaminergic neuronal activity and metabolism: similarity to other neuroleptics.
    Bunney BS; Roth RH; Aghajanian GK
    Psychopharmacol Commun; 1975; 1(4):349-58. PubMed ID: 1224004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs.
    Feigenbaum J; Yanai J; Moon B; Klawans H
    Neuropharmacology; 1983 Dec; 22(12A):1369-76. PubMed ID: 6686653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small doses of apomorphine induce catalepsy and antagonize methamphetamine stereotypy in rats.
    Balsara JJ; Bapat TR; Gada VP; Chandorkar AG
    Psychopharmacology (Berl); 1982; 78(2):192-4. PubMed ID: 6817377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
    Prosser ES; Pruthi R; Csernansky JG
    Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid influence on some aspects of stereotyped behavior induced by repeated amphetamine treatment.
    Cancela LM; Artinián J; Fulginiti S
    Pharmacol Biochem Behav; 1988 Aug; 30(4):899-904. PubMed ID: 2976168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential biochemical and behavioral effects of single and chronic administration of amphetamine and apomorphine.
    Bernardi MM; Scavone C
    Gen Pharmacol; 1985; 16(4):407-10. PubMed ID: 4043718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subchronic methamphetamine treatment selectively attenuates apomorphine-induced decrease in 3,4-dihydroxyphenylacetic acid level in mesolimbic dopaminergic regions.
    Watanabe H
    Life Sci; 1985 Dec; 37(24):2319-25. PubMed ID: 4068904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats.
    Hong M; Jenner P; Marsden CD
    Neuropharmacology; 1987; 26(2-3):237-45. PubMed ID: 2884588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity.
    Rubin EH; Wooten GF
    Psychopharmacology (Berl); 1984; 84(2):217-20. PubMed ID: 6438680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
    Vasse M; Protais P
    Neuropharmacology; 1989 Sep; 28(9):931-9. PubMed ID: 2554186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of naloxone on d-amphetamine- and apomorphine-induced behavior.
    Hitzemann R; Curell J; Hom D; Loh H
    Neuropharmacology; 1982 Oct; 21(10):1005-11. PubMed ID: 6890635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphine.
    Mogilnicka E; Braestrup C
    J Pharm Pharmacol; 1976 Mar; 28(3):253-5. PubMed ID: 6705
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sensitization of male rats to aggressive behavior by apomorphine].
    Allikmets LKh; Vasar EE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1982; 32(1):130-5. PubMed ID: 7199793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment.
    Kuczenski R; Leith NJ; Applegate CD
    Brain Res; 1983 Jan; 258(2):333-7. PubMed ID: 6824917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential dose- and time-dependent effects of molindone on dopamine neurons of rat brain: mediation by irreversible inhibition of monoamine oxidase.
    Meller E; Friedman E
    J Pharmacol Exp Ther; 1982 Mar; 220(3):609-15. PubMed ID: 6121048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.